middle.news
INOVIQ Raises $10.2m to Fast-Track Ovarian Cancer Test and CAR-Exosome Therapy
9:16am on Thursday 29th of January, 2026 AEDT
•
Healthcare
Read Story
INOVIQ Raises $10.2m to Fast-Track Ovarian Cancer Test and CAR-Exosome Therapy
9:16am on Thursday 29th of January, 2026 AEDT
Key Points
Completed $10.2m capital raise including $5m cornerstone investment
EXO-OC ovarian cancer test shows 100% sensitivity for early-stage detection
Positive in vivo proof-of-concept for CAR-exosome therapy in triple-negative breast cancer
Peter Gunzburg appointed Chairman; Dr Rebecca Lim named Chief Scientific Officer
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
INOVIQ (ASX:IIQ)
OPEN ARTICLE